These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3517137)

  • 1. An Indiana study: an original clinical approach to a fatal metabolic problem.
    Dyken ML
    Indiana Med; 1986 Mar; 79(3):234-5. PubMed ID: 3517137
    [No Abstract]   [Full Text] [Related]  

  • 2. Duchenne muscular dystrophy. A rational approach to disease comprehension and therapy.
    Bonsett CA
    Indiana Med; 1986 Mar; 79(3):236-41. PubMed ID: 3701024
    [No Abstract]   [Full Text] [Related]  

  • 3. Duchenne's muscular dystrophy: a tissue culture perspective.
    Bonsett CA; Rudman A
    Indiana Med; 1984 Jun; 77(6):446-9. PubMed ID: 6736618
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle.
    Nakahara M
    Arzneimittelforschung; 1965 Jul; 15(7):782-5. PubMed ID: 5898681
    [No Abstract]   [Full Text] [Related]  

  • 5. Identifying and circumventing the defect in Duchenne muscular dystrophy: clinical and biochemical restoration after practical intervention.
    Thomson WH
    Med Hypotheses; 1987 Oct; 24(2):187-90. PubMed ID: 3683247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on progressive muscular dystrophy. IV. Effects of original amino acids mixture on progressive muscular dystrophy.
    Nakahara M; Yamada S
    Arzneimittelforschung; 1967 Jun; 17(6):753-6. PubMed ID: 5632380
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with and considerations on therapy of progressive muscular dystrophies].
    Beckmann R
    Hippokrates; 1968 Dec; 39(23):876-88. PubMed ID: 5718770
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucose assimilation and the effect of insulin in x-chromosomal recessive hereditary muscular dystrophy (Duchenne type) in tolerance tests].
    Blietz RJ; Paulmann F
    Hoppe Seylers Z Physiol Chem; 1966; 347(1):35-51. PubMed ID: 5339785
    [No Abstract]   [Full Text] [Related]  

  • 9. An approach to treatment trials in muscular dystrophy with particular reference to agents influencing free radical damage.
    Edwards RH; Jones DA; Jackson MJ
    Med Biol; 1984; 62(2):143-7. PubMed ID: 6471933
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progressive muscular dystrophy].
    Tsuji S; Kato F; Osawa K
    Naika; 1967 Jun; 19(6):1301-3. PubMed ID: 4865513
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxidative phosphorylation and glycolysis in the hereditary muscular dystrophy of the Syrian hamster.
    Lochner A; Brink AJ
    Clin Sci; 1967 Oct; 33(2):409-23. PubMed ID: 6058438
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: controlled trials show no effect of allopurinol or ribose.
    Griffiths RD; Cady EB; Edwards RH; Wilkie DR
    Muscle Nerve; 1985; 8(9):760-7. PubMed ID: 3935926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New aspects of the management of progressive muscular dystrophy].
    Tilscher H; Schenk S
    Wien Med Wochenschr; 1967 Nov; 117(44):1000-2. PubMed ID: 5591872
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on progressive muscular dystrophy. I. Effects of adenosinetriphosphate and its related compounds on progressive muscular dystrophy.
    Nakahara M
    Arzneimittelforschung; 1965 Jun; 15(6):591-5. PubMed ID: 4223122
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical applications of NMR spectroscopy. I. Clinical applications of phosphorus-31 NMR.
    Battocletti JH
    Crit Rev Biomed Eng; 1984; 10(1):1-27. PubMed ID: 6362983
    [No Abstract]   [Full Text] [Related]  

  • 16. Contribution to the muscular dystrophy treatment.
    Tomaszkiewicz JA; Kossatz-Bielecka DE
    Pol Med Sci Hist Bull; 1968 Apr; 11(2):92. PubMed ID: 4870251
    [No Abstract]   [Full Text] [Related]  

  • 17. Ineffectiveness of allopurinol in Duchenne muscular dystrophy.
    Doriguzzi C; Bertolotto A; Ganzit GP; Mongini T; Palmucci L
    Muscle Nerve; 1981; 4(2):176-8. PubMed ID: 7010155
    [No Abstract]   [Full Text] [Related]  

  • 18. [Phosphaden in the treatment of patients with age-related macular dystrophies].
    Smoliakova GP; Cherepanova GI
    Oftalmol Zh; 1984; (8):489-91. PubMed ID: 6531176
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on progressive muscular dystrophy. 3. Breakdown of adenosine nucleotides in human blood.
    Nakahara M
    Arzneimittelforschung; 1965 Aug; 15(8):932-4. PubMed ID: 5898654
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy and macroergic phosphoric compounds in Duchenne's progressive muscular dystrophy].
    Radu H; Stenzel K; Blücher G; Gödri I
    Neurol Psihiatr Neurochir; 1969; 14(5):435-42. PubMed ID: 5380160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.